Please read before exploring Peptide Insights
Important: The information on this website is intended for educational and research purposes only.
Peptide Insights provides information about peptides based on published scientific research and clinical literature. This content is designed to help you understand the science, not to guide personal medical decisions.
By continuing, you confirm that you are accessing this information for educational purposes and understand that it does not constitute medical advice.
Bremelanotide · Vyleesi
The first FDA-approved peptide for sexual dysfunction in women
Typical Dose
1.75 mg per dose
Route
Subcutaneous
Frequency
As needed, 45 minutes before sexual activity
Cycle
As needed (not daily)
PT-141 is the first FDA-approved peptide specifically for low sexual desire in women, and it works in a completely different way from medications like Viagra. Viagra and similar drugs work on blood flow. PT-141 works on your brain — specifically the part that controls desire and arousal. It is effective for both men and women, and it addresses the psychological side of sexual health, not just the physical. Many people find this distinction important, especially when low desire is the issue rather than physical function.
PT-141 activates specific receptors in the hypothalamus — the part of your brain that regulates desire, motivation, and arousal. This triggers a release of dopamine, your brain's reward and motivation chemical. The result is an increase in sexual desire that comes from the brain's own chemistry, not from artificially forcing blood flow. This is why it can work even when the issue is psychological rather than purely physical.
Typical Dose
1.75 mg per dose
Dose Range
0.75–2 mg per dose
Frequency
As needed, 45 minutes before sexual activity
Route
Subcutaneous injection or intranasal
Cycle Length
As needed (not daily)
CLINICAL NOTES
Do not use more than once every 24 hours. FDA-approved dose is 1.75 mg subcutaneously.
IMPORTANT DISCLAIMER
This information is for educational purposes only. Always consult a qualified healthcare provider before starting any peptide protocol. Individual responses vary and medical supervision is recommended.
PT-141 (Bremelanotide) is a sexual health peptide. It can be combined with other peptides for enhanced effects.
Oxytocin enhances emotional bonding and intimacy alongside PT-141's arousal effects.
Kisspeptin-10 supports LH/FSH release and libido through a different pathway than PT-141.
BPC-157 can help with any injection site reactions and supports overall wellbeing.
Real experiences from the Peptide Insights community
Have experience with PT-141?
Log in to share your experience and help the community.
No reviews yet for PT-141
Be the first to share your experience.